Buying a Pharmacy

Pharmacy acquisitions involve more regulatory oversight than almost any other small business purchase. DEA registration, state pharmacy board licensing, PBM (pharmacy benefit manager) contract transfers, and controlled substance inventory requirements create a web of compliance obligations. Each regulatory body has its own transfer timeline, and missing any one can delay closing by months.

Typical deal: $300K - $5M Structure: Asset Purchase

Request Engagement Assessment Key Legal Issues

Selective M&A Practice

Competitive Rates

Managing Partner on Every Deal

The Pharmacy Acquisition Landscape

The U.S. independent pharmacy market includes approximately 21,000 locations, down from over 30,000 a decade ago. Consolidation pressure from chain pharmacies and PBM reimbursement squeezes continues to create acquisition opportunities. Independent pharmacies that survive often serve specialty niches, compounding, or long-term care markets with better margins.

Key Legal Considerations

Pharmacy acquisitions involve industry-specific legal issues that general business attorneys often miss:

DEA registration transfer for controlled substance dispensing

State pharmacy board licensing and change of ownership approval

PBM (pharmacy benefit manager) contract assignments and reimbursement terms

HIPAA compliance for patient prescription record transfers

Controlled substance inventory count and chain-of-custody requirements

340B program eligibility verification (if applicable)

Due Diligence Checklist: Pharmacy Acquisition

Before closing on a pharmacy purchase, verify each of these items:

Verify DEA registration status and any pending enforcement actions
Review state pharmacy board compliance history and inspection reports
Analyze PBM contract terms, reimbursement rates, and assignability
Assess prescription volume trends and payer mix for trailing 3 years
Review controlled substance handling procedures and inventory records
Verify HIPAA compliance program and any prior breach incidents
Evaluate specialty pharmacy services and associated certifications

Common Deal Killers

These issues kill more pharmacy acquisitions than bad economics:

PBM contracts non-assignable or reimbursement rates reduced upon transfer

State pharmacy board licensing delays exceed deal timeline

DEA compliance issues in the seller's history that affect transfer

Why Legal Counsel Matters

Pharmacy acquisitions require coordination with federal (DEA) and state (pharmacy board) regulators simultaneously, plus negotiation with PBMs whose contracts control your revenue. Your attorney needs to understand healthcare regulatory timelines and ensure all approvals align with your closing schedule.

Our Process: Pharmacy Acquisitions

A structured approach to pharmacy acquisition counsel

LOI and Regulatory Assessment

We review the letter of intent, identify all required regulatory approvals, and create a timeline for parallel processing of DEA, state board, and PBM requirements.

Regulatory Filings

We initiate state pharmacy board change of ownership application, DEA registration, and PBM contract assignment requests simultaneously.

Due Diligence

Prescription volume analysis, PBM reimbursement review, compliance history audit, controlled substance inventory assessment, and HIPAA compliance evaluation.

Purchase Agreement Negotiation

We negotiate the purchase agreement with pharmacy-specific provisions: regulatory approval contingencies, inventory valuation methodology, PBM assignment conditions, and HIPAA compliance.

Closing

Controlled substance inventory count, DEA transfer, patient record custody transfer, PBM contract assignments, and final regulatory notifications.

Request Engagement Assessment

Frequently Asked Questions

Common questions about buying a pharmacy

Do I need a pharmacist license to buy a pharmacy?

Requirements vary by state. Some states require the pharmacy owner to be a licensed pharmacist, while others allow non-pharmacist ownership as long as a licensed pharmacist-in-charge is employed. Your attorney should verify the specific ownership requirements in your state before structuring the deal.

How does the DEA registration transfer work?

The buyer must obtain a new DEA registration for the pharmacy location. This requires a completed DEA Form 224, a state pharmacy license, and background clearance. The process typically takes 4 to 8 weeks. A controlled substance inventory must be conducted at the time of transfer.

What are PBM contracts and why do they matter?

PBM contracts determine the reimbursement rates for prescription drugs. Since PBM reimbursement represents the majority of pharmacy revenue, the terms of these contracts directly affect profitability. Your attorney should review all PBM contracts for assignability, reimbursement rates, and any change-of-ownership provisions.

What happens to prescription records when a pharmacy is sold?

Patient prescription records must transfer in compliance with HIPAA and state pharmacy board rules. The buyer assumes custody of all records and becomes responsible for ongoing privacy and security obligations. Proper record transfer protocols should be included in the purchase agreement.

How long does it take to buy a pharmacy?

Pharmacy acquisitions typically take 90 to 150 days from signed LOI to closing. The timeline is driven by state pharmacy board approval (30 to 90 days), DEA registration (4 to 8 weeks), and PBM contract assignments. These regulatory processes should run in parallel.

Need Specific Guidance?

Submit your transaction details for a preliminary assessment by our managing partner

Submit Transaction Details